Article
EGFR mutations in Indian lung cancer patients: clinical correlation and outcome to EGFR targeted therapy.
PloS one - 1 Jan 2013
Noronha Vanita, Prabhash Kumar, Thavamani Abhishek, Chougule Anuradha, Purandare Nilendu, Joshi Amit, Sharma Rashmi, Desai Saral, Jambekar Nirmala, Dutt Amit, Mulherkar Rita
Abstract excerpt
Screening for EGFR mutation is a key molecular test for management of lung cancer patients. Outcome of patients with mutation receiving EGFR tyrosine kinase inhibitor is known to be better across different ethnic populations. However, frequency of EGFR mutations and the clinical response in most...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.